Makizako H, Nakai Y, Tomioka K, et al. Prevalence of sarcopenia defined using the Asia Working Group for Sarcopenia criteria in Japanese community-dwelling older adults: a systematic review and meta-analysis. Phys Ther Res. 2019;22:53–7.
Article PubMed PubMed Central Google Scholar
Parvatiyar MS, Qaisar R. Editorial: skeletal muscle in age-related diseases: from molecular pathogenesis to potential interventions. Front Physiol. 2022;13:1056479.
Article PubMed PubMed Central Google Scholar
Beaudart C, Locquet M, Reginster JY, et al. Quality of life in sarcopenia measured with the SarQoL(R): impact of the use of different diagnosis definitions. Aging Clin Exp Res. 2018;30:307–13.
Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44:960–6.
Article PubMed PubMed Central Google Scholar
Konstantynowicz J, Abramowicz P, Glinkowski W, et al. Polish validation of the SarQoL((R)), a quality of life questionnaire specific to sarcopenia. J Clin Med. 2018;7:323.
Article PubMed PubMed Central Google Scholar
Erdogan T, Eris S, Avci S, et al. Sarcopenia quality-of-life questionnaire (SarQoL)(R): translation, cross-cultural adaptation and validation in Turkish. Aging Clin Exp Res. 2021;33:2979–88.
Beaudart C, Edwards M, Moss C, et al. English translation and validation of the SarQoL(R), a quality of life questionnaire specific for sarcopenia. Age Ageing. 2017;46:271–6.
Geerinck A, Dawson-Hughes B, Beaudart C, et al. Assessment of the performance of the SarQoL((R)) questionnaire in screening for sarcopenia in older people. Aging Clin Exp Res. 2021;33:2149–55.
Gong H, Liu Y, Lyu X, et al. Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function. Exp Gerontol. 2022;159: 111668.
Article CAS PubMed Google Scholar
Bouitbir J, Sanvee GM, Panajatovic MV, et al. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res. 2020;154: 104201.
Article CAS PubMed Google Scholar
Qaisar R, Karim A, Muhammad T, et al. Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications. Respir Med. 2023;215: 107298.
Monti E, Sarto F, Sartori R, et al. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J Cachexia Sarcopenia Muscle. 2023;14:730–44.
Article PubMed PubMed Central Google Scholar
Bhaskaran S, Pollock N, Macpherson P, et al. Neuron-specific deletion of CuZnSOD leads to an advanced sarcopenic phenotype in older mice. Aging Cell. 2020;19: e13225.
Article CAS PubMed PubMed Central Google Scholar
Qaisar R, Karim A, Muhammad T. Plasma CAF22 levels as a useful predictor of muscle health in patients with chronic obstructive pulmonary disease. Biology (Basel). 2020;9:166.
Peyrel P, Mauriege P, Frenette J, et al. Statin withdrawal and health-related quality of life in a primary cardiovascular prevention cohort. Qual Life Res. 2023;32:1943.
Article CAS PubMed Google Scholar
Strandberg TE, Urtamo A, Kahara J, et al. Statin treatment is associated with a neutral effect on health-related quality of life among community-dwelling octogenarian men: the helsinki businessmen study. J Gerontol A Biol Sci Med Sci. 2018;73:1418–23.
Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or lipophilic statins? Front Cardiovasc Med. 2021;8: 687585.
Article CAS PubMed PubMed Central Google Scholar
Karim A, Muhammad T, Ustrana S, et al. Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease. Respir Med. 2021;189: 106662.
Qaisar R, Karim A, Muhammad T, et al. The coupling between sarcopenia and COVID-19 is the real problem. Eur J Intern Med. 2021;93:105–6.
Article CAS PubMed PubMed Central Google Scholar
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.
Karim A, Muhammad T, Iqbal MS, et al. Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men. Exp Gerontol. 2023;171: 112034.
Article CAS PubMed Google Scholar
Ahmad F, Karim A, Khan J, et al. Plasma zonulin correlates with cardiac dysfunction and poor physical performance in patients with chronic heart failure. Life Sci. 2022;311: 121150.
Article CAS PubMed Google Scholar
Visvanathan R, Yu S, Field J, et al. Appendicular skeletal muscle mass: development and validation of anthropometric prediction equations. J Frailty Aging. 2012;1:147–51.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing group for the European Working Group on Sarcopenia in older, E. the Extended Group for, sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:601.
Article PubMed PubMed Central Google Scholar
Qaisar R, Iqbal MS, Karim A, et al. A leaky gut contributes to reduced sarcopenia-related quality of life (SarQoL) in geriatric older adults. Qual Life Res. 2023;33:551–9.
Guillamon-Escudero C, Diago-Galmes A, Zuazua Rico D, et al. SarQoL questionnaire in community-dwelling older adults under EWGSOP2 sarcopenia diagnosis algorithm: a new screening method? Int J Environ Res Public Health. 2022;19:8473.
Article PubMed PubMed Central Google Scholar
Gupta A, Jayakumar MN, Saleh MA, et al. SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis. Life Sci. 2022;304: 120703.
Article CAS PubMed PubMed Central Google Scholar
Qaisar R, Qayum M, Muhammad T. Reduced sarcoplasmic reticulum Ca2+ ATPase activity underlies skeletal muscle wasting in asthma. Life Sci. 2021;273: 119296.
Article CAS PubMed Google Scholar
Karim A, Muhammad T, Shahid Iqbal M, et al. A multistrain probiotic improves handgrip strength and functional capacity in patients with COPD: a randomized controlled trial. Arch Gerontol Geriatr. 2022;102:104721.
Article CAS PubMed Google Scholar
De Giorgi R, Rizzo Pesci N, Quinton A, et al. Statins in depression: an evidence-based overview of mechanisms and clinical studies. Front Psychiatry. 2021;12:702617.
Article PubMed PubMed Central Google Scholar
Cham S, Koslik HJ, Golomb BA. Mood, personality, and behavior changes during treatment with statins: a case series. Drug Saf Case Rep. 2016;3:1.
Gasparik AI, Mihai G, Beaudart C, et al. Psychometric performance of the Romanian version of the SarQoL(R), a health-related quality of life questionnaire for sarcopenia. Arch Osteoporos. 2017;12:103.
Vinci P, Panizon E, Tosoni LM, et al. Statin-associated myopathy: emphasis on mechanisms and targeted therapy. Int J Mol Sci. 2021;22:11687.
Article CAS PubMed PubMed Central Google Scholar
Murinson BB, Haughey NJ, Maragakis NJ. Selected statins produce rapid spinal motor neuron loss in vitro. BMC Musculoskelet Disord. 2012;13:100.
Article CAS PubMed PubMed Central Google Scholar
Ahmadi Y, Ghorbanihaghjo A, Naghi-Zadeh M, et al. Oxidative stress as a possible mechanism of statin-induced myopathy. Inflammopharmacology. 2018;26:667–74.
Article CAS PubMed Google Scholar
Brown JL, Lawrence MM, Ahn B, et al. Cancer cachexia in a mouse model of oxidative stress. J Cachexia Sarcopenia Muscle. 2020;11:1688–704.
Article PubMed PubMed Central Google Scholar
Qaisar R, Karim A, Iqbal MS, et al. A leaky gut contributes to postural dysfunction in patients with Alzheimer’s disease. Heliyon. 2023;9: e19485.
Article CAS PubMed PubMed Central Google Scholar
Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045.
留言 (0)